Hypogonadotropic Hypogonadism Revisited
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.6061/clinics/2013(Sup01)09 http://repositorio.unifesp.br/handle/11600/35766 |
Resumo: | Impaired testicular function, i.e., hypogonadism, can result from a primary testicular disorder (hypergonadotropic) or occur secondary to hypothalamic-pituitary dysfunction (hypogonadotropic).Hypogonadotropic hypogonadism can be congenital or acquired. Congenital hypogonadotropic hypogonadism is divided into anosmic hypogonadotropic hypogonadism (Kallmann syndrome) and congenital normosmic isolated hypogonadotropic hypogonadism (idiopathic hypogonadotropic hypogonadism). the incidence of congenital hypogonadotropic hypogonadism is approximately 1-10:100,000 live births, and approximately 2/3 and 1/3 of cases are caused by Kallmann syndrome (KS) and idiopathic hypogonadotropic hypogonadism, respectively.Acquired hypogonadotropic hypogonadism can be caused by drugs, infiltrative or infectious pituitary lesions, hyperprolactinemia, encephalic trauma, pituitary/brain radiation, exhausting exercise, abusive alcohol or illicit drug intake, and systemic diseases such as hemochromatosis, sarcoidosis and histiocytosis X.The clinical characteristics of hypogonadotropic hypogonadism are androgen deficiency and a lack/delay/stop of pubertal sexual maturation. Low blood testosterone levels and low pituitary hormone levels confirm the hypogonadotropic hypogonadism diagnosis. A prolonged stimulated intravenous GnRH test can be useful. in Kallmann syndrome, cerebral MRI can show an anomalous morphology or even absence of the olfactory bulb. Therapy for hypogonadotropic hypogonadism depends on the patient's desire for future fertility. Hormone replacement with testosterone is the classic treatment for hypogonadism. Androgen replacement is indicated for men who already have children or have no desire to induce pregnancy, and testosterone therapy is used to reverse the symptoms and signs of hypogonadism. Conversely, GnRH or gonadotropin therapies are the best options for men wishing to have children. Hypogonadotropic hypogonadism is one of the rare conditions in which specific medical treatment can reverse infertility.When an unassisted pregnancy is not achieved, assisted reproductive techniques ranging from intrauterine insemination to in vitro fertilization to the acquisition of viable sperm from the ejaculate or directly from the testes through testicular sperm extraction or testicular microdissection can also be used, depending on the woman's potential for pregnancy and the quality and quantity of the sperm. |
id |
UFSP_0c09329e183e15dbfcdc0dbaf89e86cb |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/35766 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Hypogonadotropic Hypogonadism RevisitedMale InfertilityHypogonadismEndocrine System AbnormalitiesAzoospermiaReviewImpaired testicular function, i.e., hypogonadism, can result from a primary testicular disorder (hypergonadotropic) or occur secondary to hypothalamic-pituitary dysfunction (hypogonadotropic).Hypogonadotropic hypogonadism can be congenital or acquired. Congenital hypogonadotropic hypogonadism is divided into anosmic hypogonadotropic hypogonadism (Kallmann syndrome) and congenital normosmic isolated hypogonadotropic hypogonadism (idiopathic hypogonadotropic hypogonadism). the incidence of congenital hypogonadotropic hypogonadism is approximately 1-10:100,000 live births, and approximately 2/3 and 1/3 of cases are caused by Kallmann syndrome (KS) and idiopathic hypogonadotropic hypogonadism, respectively.Acquired hypogonadotropic hypogonadism can be caused by drugs, infiltrative or infectious pituitary lesions, hyperprolactinemia, encephalic trauma, pituitary/brain radiation, exhausting exercise, abusive alcohol or illicit drug intake, and systemic diseases such as hemochromatosis, sarcoidosis and histiocytosis X.The clinical characteristics of hypogonadotropic hypogonadism are androgen deficiency and a lack/delay/stop of pubertal sexual maturation. Low blood testosterone levels and low pituitary hormone levels confirm the hypogonadotropic hypogonadism diagnosis. A prolonged stimulated intravenous GnRH test can be useful. in Kallmann syndrome, cerebral MRI can show an anomalous morphology or even absence of the olfactory bulb. Therapy for hypogonadotropic hypogonadism depends on the patient's desire for future fertility. Hormone replacement with testosterone is the classic treatment for hypogonadism. Androgen replacement is indicated for men who already have children or have no desire to induce pregnancy, and testosterone therapy is used to reverse the symptoms and signs of hypogonadism. Conversely, GnRH or gonadotropin therapies are the best options for men wishing to have children. Hypogonadotropic hypogonadism is one of the rare conditions in which specific medical treatment can reverse infertility.When an unassisted pregnancy is not achieved, assisted reproductive techniques ranging from intrauterine insemination to in vitro fertilization to the acquisition of viable sperm from the ejaculate or directly from the testes through testicular sperm extraction or testicular microdissection can also be used, depending on the woman's potential for pregnancy and the quality and quantity of the sperm.Fed Univ São Paulo UNIFESP, Dept Surg, Div Urol, São Paulo, BrazilANDROFERT Androl & Human Reprod Clin, Campinas, SP, BrazilFed Univ São Paulo UNIFESP, Dept Surg, Div Urol, São Paulo, BrazilWeb of ScienceHospital Clinicas, Univ São PauloUniversidade Federal de São Paulo (UNIFESP)ANDROFERT Androl & Human Reprod ClinFraietta, Renato [UNIFESP]Zylberstejn, Daniel Suslik [UNIFESP]Esteves, Sandro C.2016-01-24T14:30:59Z2016-01-24T14:30:59Z2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion81-88application/pdfhttp://dx.doi.org/10.6061/clinics/2013(Sup01)09Clinics. São Paulo: Hospital Clinicas, Univ São Paulo, v. 68, p. 81-88, 2013.10.6061/clinics/2013(Sup01)09S1807-59322013001300009.pdf1807-5932S1807-59322013001300009http://repositorio.unifesp.br/handle/11600/35766WOS:000316127300009engClinicsinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-01T04:51:51Zoai:repositorio.unifesp.br/:11600/35766Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-01T04:51:51Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Hypogonadotropic Hypogonadism Revisited |
title |
Hypogonadotropic Hypogonadism Revisited |
spellingShingle |
Hypogonadotropic Hypogonadism Revisited Fraietta, Renato [UNIFESP] Male Infertility Hypogonadism Endocrine System Abnormalities Azoospermia Review |
title_short |
Hypogonadotropic Hypogonadism Revisited |
title_full |
Hypogonadotropic Hypogonadism Revisited |
title_fullStr |
Hypogonadotropic Hypogonadism Revisited |
title_full_unstemmed |
Hypogonadotropic Hypogonadism Revisited |
title_sort |
Hypogonadotropic Hypogonadism Revisited |
author |
Fraietta, Renato [UNIFESP] |
author_facet |
Fraietta, Renato [UNIFESP] Zylberstejn, Daniel Suslik [UNIFESP] Esteves, Sandro C. |
author_role |
author |
author2 |
Zylberstejn, Daniel Suslik [UNIFESP] Esteves, Sandro C. |
author2_role |
author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) ANDROFERT Androl & Human Reprod Clin |
dc.contributor.author.fl_str_mv |
Fraietta, Renato [UNIFESP] Zylberstejn, Daniel Suslik [UNIFESP] Esteves, Sandro C. |
dc.subject.por.fl_str_mv |
Male Infertility Hypogonadism Endocrine System Abnormalities Azoospermia Review |
topic |
Male Infertility Hypogonadism Endocrine System Abnormalities Azoospermia Review |
description |
Impaired testicular function, i.e., hypogonadism, can result from a primary testicular disorder (hypergonadotropic) or occur secondary to hypothalamic-pituitary dysfunction (hypogonadotropic).Hypogonadotropic hypogonadism can be congenital or acquired. Congenital hypogonadotropic hypogonadism is divided into anosmic hypogonadotropic hypogonadism (Kallmann syndrome) and congenital normosmic isolated hypogonadotropic hypogonadism (idiopathic hypogonadotropic hypogonadism). the incidence of congenital hypogonadotropic hypogonadism is approximately 1-10:100,000 live births, and approximately 2/3 and 1/3 of cases are caused by Kallmann syndrome (KS) and idiopathic hypogonadotropic hypogonadism, respectively.Acquired hypogonadotropic hypogonadism can be caused by drugs, infiltrative or infectious pituitary lesions, hyperprolactinemia, encephalic trauma, pituitary/brain radiation, exhausting exercise, abusive alcohol or illicit drug intake, and systemic diseases such as hemochromatosis, sarcoidosis and histiocytosis X.The clinical characteristics of hypogonadotropic hypogonadism are androgen deficiency and a lack/delay/stop of pubertal sexual maturation. Low blood testosterone levels and low pituitary hormone levels confirm the hypogonadotropic hypogonadism diagnosis. A prolonged stimulated intravenous GnRH test can be useful. in Kallmann syndrome, cerebral MRI can show an anomalous morphology or even absence of the olfactory bulb. Therapy for hypogonadotropic hypogonadism depends on the patient's desire for future fertility. Hormone replacement with testosterone is the classic treatment for hypogonadism. Androgen replacement is indicated for men who already have children or have no desire to induce pregnancy, and testosterone therapy is used to reverse the symptoms and signs of hypogonadism. Conversely, GnRH or gonadotropin therapies are the best options for men wishing to have children. Hypogonadotropic hypogonadism is one of the rare conditions in which specific medical treatment can reverse infertility.When an unassisted pregnancy is not achieved, assisted reproductive techniques ranging from intrauterine insemination to in vitro fertilization to the acquisition of viable sperm from the ejaculate or directly from the testes through testicular sperm extraction or testicular microdissection can also be used, depending on the woman's potential for pregnancy and the quality and quantity of the sperm. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-01-01 2016-01-24T14:30:59Z 2016-01-24T14:30:59Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.6061/clinics/2013(Sup01)09 Clinics. São Paulo: Hospital Clinicas, Univ São Paulo, v. 68, p. 81-88, 2013. 10.6061/clinics/2013(Sup01)09 S1807-59322013001300009.pdf 1807-5932 S1807-59322013001300009 http://repositorio.unifesp.br/handle/11600/35766 WOS:000316127300009 |
url |
http://dx.doi.org/10.6061/clinics/2013(Sup01)09 http://repositorio.unifesp.br/handle/11600/35766 |
identifier_str_mv |
Clinics. São Paulo: Hospital Clinicas, Univ São Paulo, v. 68, p. 81-88, 2013. 10.6061/clinics/2013(Sup01)09 S1807-59322013001300009.pdf 1807-5932 S1807-59322013001300009 WOS:000316127300009 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Clinics |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
81-88 application/pdf |
dc.publisher.none.fl_str_mv |
Hospital Clinicas, Univ São Paulo |
publisher.none.fl_str_mv |
Hospital Clinicas, Univ São Paulo |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268303279915008 |